via The Scientist RSS https://ift.tt/3wRkXRH With multiple microbiota therapeutics in the pipeline for recurrent Clostridium difficile infection, clinicians foresee a shift in treatment options for the condition. https://ift.tt/eA8V8J June 01, 2021 at 09:30AM